Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
The American Journal of Gastroenterology
|
January 5, 2002
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
D C Metz, C Forsmark, E A Lew, et al.
Journal of Diabetes and Its Complications
|
July 1, 1993
Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group
J V Santiago, P H Snksen, A J Boulton, et al.
Gastroenterology
|
March 29, 2000
Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
E A Lew, J R Pisegna, J A Starr, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
The American Journal of Gastroenterology
|
January 5, 2002
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
D C Metz, C Forsmark, E A Lew, et al.
Journal of Diabetes and Its Complications
|
July 1, 1993
Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group
J V Santiago, P H Snksen, A J Boulton, et al.
Gastroenterology
|
March 29, 2000
Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
E A Lew, J R Pisegna, J A Starr, et al.
Page
of 2